9369134

Source:http://linkedlifedata.com/resource/pubmed/id/9369134

Download in:

Switch to

Custom View

Named Graph Language Inference

Statements in which the resource exists as a subject.
Predicate	Object
rdf:type	pubmed:Citation
lifeskim:mentions	umls-concept:C0008976, umls-concept:C0059682, umls-concept:C0150369, umls-concept:C0201734, umls-concept:C0205390, umls-concept:C0460004, umls-concept:C1514695, umls-concept:C1707811
pubmed:issue	4
pubmed:dateCreated	1997-11-25
pubmed:abstractText	To prospectively evaluate the pharmacokinetic monitoring and drug dose adjustment of Etanidazole (Eta) in patients treated on the RTOG randomized trial for Stage III and IV head and neck cancer.
pubmed:grant	http://linkedlifedata.com/resource/pubmed/grant/CA-21661, http://linkedlifedata.com/resource/pubmed/grant/CA-32115, http://linkedlifedata.com/resource/pubmed/grant/CA-42391
pubmed:language	eng
pubmed:journal	http://linkedlifedata.com/resource/pubmed/journal/7603616
pubmed:citationSubset	IM
pubmed:chemical	http://linkedlifedata.com/resource/pubmed/chemical/Antineoplastic Agents, http://linkedlifedata.com/resource/pubmed/chemical/Etanidazole, http://linkedlifedata.com/resource/pubmed/chemical/Radiation-Sensitizing Agents
pubmed:status	MEDLINE
pubmed:month	Nov
pubmed:issn	0360-3016
pubmed:author	pubmed-author:BuswellLL, pubmed-author:ColemanC NCN, pubmed-author:LeeD JDJ, pubmed-author:LongJ GJG, pubmed-author:PajakT FTF, pubmed-author:RieseN ENE, pubmed-author:StetzJJ
pubmed:issnType	Print
pubmed:day	1
pubmed:volume	39
pubmed:owner	NLM
pubmed:authorsComplete	Y
pubmed:pagination	855-8
pubmed:dateRevised	2007-11-14
pubmed:meshHeading	pubmed-meshheading:9369134-Antineoplastic Agents, pubmed-meshheading:9369134-Area Under Curve, pubmed-meshheading:9369134-Disease-Free Survival, pubmed-meshheading:9369134-Etanidazole, pubmed-meshheading:9369134-Head and Neck Neoplasms, pubmed-meshheading:9369134-Humans, pubmed-meshheading:9369134-Multivariate Analysis, pubmed-meshheading:9369134-Neoplasm Staging, pubmed-meshheading:9369134-Peripheral Nervous System Diseases, pubmed-meshheading:9369134-Prospective Studies, pubmed-meshheading:9369134-Radiation-Sensitizing Agents
pubmed:year	1997
pubmed:articleTitle	Pharmacokinetic monitoring and dose modification of etanidazole in the RTOG 85-27 phase III head and neck trial.
pubmed:affiliation	Joint Center for Radiation Therapy, Harvard Medical School, Boston, MA 02215, USA.
pubmed:publicationType	Journal Article, Clinical Trial, Research Support, U.S. Gov't, P.H.S., Randomized Controlled Trial, Clinical Trial, Phase III